• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

Oral prostaglandin and intravenous oxytocin for induction of labour: Maternal side effects

    Dr. Kodali Radhika, Dr. PSLK Prasanthi, Dr. Vijayalaxmi Upputuri

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 3794-3797

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Induction of labour is an obstetric procedure designed to pre-empt the natural process of labour by initiating its onset artificially before this occurs spontaneously. The ultimate weapon at the disposal of the obstetrician is intervention to deliver the baby. This can be done by Induction or caesarean section. His decision to take thestep relies on assessment of the “Obstetric balance”. The present study is a comparative study between oral prostaglandin E2 (PGE2) and intravenous oxytocin (IV oxytocin) for induction of labour carried out at Hospital.One hundred and twenty consecutive patients stated for induction of labour satisfying the selection criteria for the study were alternately recruited to Prostaglandin or oxytocin groups. The maternal side effects were more in the prostaglandin group.One occurrence of hypertonic uterine action a case of premature rupture of membranes in the PGE2 group. Post-partum hemorrhage was observed in 2 of the 43 patients of oral PGE2 and in 6 of the 45 patients induced with oxytocin.
Keywords:
  • PDF (152 K)
  • XML
(2022). Oral prostaglandin and intravenous oxytocin for induction of labour: Maternal side effects. European Journal of Molecular & Clinical Medicine, 9(4), 3794-3797.
Dr. Kodali Radhika, Dr. PSLK Prasanthi, Dr. Vijayalaxmi Upputuri. "Oral prostaglandin and intravenous oxytocin for induction of labour: Maternal side effects". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 3794-3797.
(2022). 'Oral prostaglandin and intravenous oxytocin for induction of labour: Maternal side effects', European Journal of Molecular & Clinical Medicine, 9(4), pp. 3794-3797.
Oral prostaglandin and intravenous oxytocin for induction of labour: Maternal side effects. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 3794-3797.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 41
  • PDF Download: 51
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus